2019
DOI: 10.1007/s12640-019-00039-5
|View full text |Cite
|
Sign up to set email alerts
|

Engagement of MicroRNA-155 in Exaggerated Oxidative Stress Signal and TRPA1 in the Dorsal Horn of the Spinal Cord and Neuropathic Pain During Chemotherapeutic Oxaliplatin

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

1
30
0

Year Published

2020
2020
2023
2023

Publication Types

Select...
6

Relationship

0
6

Authors

Journals

citations
Cited by 32 publications
(31 citation statements)
references
References 65 publications
1
30
0
Order By: Relevance
“…In general, cytotoxic drugs used for chemotherapy activate oxidative stress signals and thereby induce peripheral neuropathy (35,54,55). The previous study has demonstrated that TRPA1 is activated in the process of BTZ-induced pain and oxidative stress is involved in activation of the signal pathways (55).…”
Section: Discussionmentioning
confidence: 99%
See 4 more Smart Citations
“…In general, cytotoxic drugs used for chemotherapy activate oxidative stress signals and thereby induce peripheral neuropathy (35,54,55). The previous study has demonstrated that TRPA1 is activated in the process of BTZ-induced pain and oxidative stress is involved in activation of the signal pathways (55).…”
Section: Discussionmentioning
confidence: 99%
“…After the end of BTZ administration, the following intrathecal injection was performed each day for three consecutive days: miR-155 inhibitor (sequence: 5 ′ AAU UAC GAU UAG CAC UAU CCC CA-3 ′ ; 3 µg, Biomics Biotech, Nantong, China), miR-155 mimics (sequence: 5 ′ -UUA AUG CUA AUC GUG AUA GGG GU-3 ′ ; 3 µg, Biomics Biotech, Nantong, China) and their corresponding scramble for negative controls (3 µg, Biomics Biotech, Nantong, China). MiR-155 inhibitor, miR-155 mimics and their respective scramble were dissolved in artificial cerebrospinal fluid (aCSF) before they were used; and their dosages used in this study were based on the published work (35). TNF-α synthesis inhibitor pentoxifylline (PTX, 10 µg), TRPA1 antagonist HC030031 (5 µg), p38-MAPK inhibitor SB203580 (5 µg), and JNK inhibitor SP600125 (5 µg) were also given by individual intrathecal injection each day for three consecutive days.…”
Section: Development Of Neuropathic Pain and Intrathecal Administrationmentioning
confidence: 99%
See 3 more Smart Citations